標(biāo)題: Titlebook: Medical Devices and In Vitro Diagnostics; Requirements in Euro Christian Baumgartner,Johann Harer ,J?rg Schr?ttne Reference work 2023 Sprin [打印本頁] 作者: 分類 時(shí)間: 2025-3-21 17:36
書目名稱Medical Devices and In Vitro Diagnostics影響因子(影響力)
書目名稱Medical Devices and In Vitro Diagnostics影響因子(影響力)學(xué)科排名
書目名稱Medical Devices and In Vitro Diagnostics網(wǎng)絡(luò)公開度
書目名稱Medical Devices and In Vitro Diagnostics網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Medical Devices and In Vitro Diagnostics被引頻次
書目名稱Medical Devices and In Vitro Diagnostics被引頻次學(xué)科排名
書目名稱Medical Devices and In Vitro Diagnostics年度引用
書目名稱Medical Devices and In Vitro Diagnostics年度引用學(xué)科排名
書目名稱Medical Devices and In Vitro Diagnostics讀者反饋
書目名稱Medical Devices and In Vitro Diagnostics讀者反饋學(xué)科排名
作者: 裝飾 時(shí)間: 2025-3-21 23:14 作者: 冥想后 時(shí)間: 2025-3-22 01:45 作者: 陪審團(tuán) 時(shí)間: 2025-3-22 08:38 作者: 蕁麻 時(shí)間: 2025-3-22 09:17
Robert Neubauer,J?rg Schr?ttner,Christian Baumgartnerich comprise eight distinct cellular lineages. In normal health, the circulating levels of mature cells are remarkably invariant, suggesting that their production is tightly regulated. However, the haemopoietic system is also flexible, allowing fluctuations in the levels of various cell types to mee作者: conspicuous 時(shí)間: 2025-3-22 13:02
Sara Stoppacher,Peter S. Müllnerolated nearly 25 years ago (Cohen 1962) and is presently the best characterized epithelial cell mitogen. Although a great deal is known about the structure of both EGF and its receptor, including the primary sequences, several important questions remain unanswered. First, what is the physiological f作者: 殘廢的火焰 時(shí)間: 2025-3-22 20:43
Wolfgang Eckeretween the products of these cellular proto-oncogenes (c-. genes) and their viral counterparts (v-. genes) has been an important issue. Comparison of the c-. gene product to that of the v-. gene encoded by the Rous sarcoma virus (RSV) indicated that the two proteins are similar in size and enzyme ac作者: FEMUR 時(shí)間: 2025-3-23 00:08
Wolfgang Eckerund Brechungsgesetz) stehen, vom Fermatschen Prinzip oder von der Huygensschen Elementarwellenkonstruktion ableitbar sind. Keine dieser Methoden kann jedoch voraussagen, wieviel Licht jeweils im reflektierten und im transmittierten Strahl wiederzufinden ist. Es ist daher eine umfassendere Theorie n?作者: Picks-Disease 時(shí)間: 2025-3-23 04:15
Karin Schwenoha,Johann Harerund Brechungsgesetz) stehen, vom Fermatschen Prinzip oder von der Huygensschen Elementarwellenkonstruktion ableitbar sind. Keine dieser Methoden kann jedoch voraussagen, wieviel Licht jeweils im reflektierten und im transmittierten Strahl wiederzufinden ist. Es ist daher eine umfassendere Theorie n?作者: 任命 時(shí)間: 2025-3-23 06:57
Elizma Parryresponses and bradycardia upon intracisternal (i. c.) injection into the alpha-chloralose anesthetized rat [1]. Leu- and met-enkephalin and alpha neo-endorphin administered in the same way preferentially produced vasopressor actions, which with the two latter peptides were associated with bradycardi作者: Vertebra 時(shí)間: 2025-3-23 09:57 作者: 沒有準(zhǔn)備 時(shí)間: 2025-3-23 16:50
Clemens Borkenstein,Marie-Astrid Haibl,Johann Harerresponses and bradycardia upon intracisternal (i. c.) injection into the alpha-chloralose anesthetized rat [1]. Leu- and met-enkephalin and alpha neo-endorphin administered in the same way preferentially produced vasopressor actions, which with the two latter peptides were associated with bradycardi作者: 永久 時(shí)間: 2025-3-23 18:36 作者: Liberate 時(shí)間: 2025-3-23 23:33 作者: 一起平行 時(shí)間: 2025-3-24 02:22
Johann Harerst at the end of the 19th century. From that time, histological data have sub- stantially studies of the pioneers in botanical science. From the beginning of the 20th century, the microscope allowed research in cell structure, the general functional unit of living beings. Advances in cytology gradua作者: 傻瓜 時(shí)間: 2025-3-24 09:58
Johann Harerend of the 19th century. From that time, histological data have sub- stantially studies of the pioneers in botanical science. From the beginning of the 20th century, the microscope allowed research in cell structure, the general functional unit of living beings. Advances in cytology gradually influe作者: colloquial 時(shí)間: 2025-3-24 13:36
Andrej Smogavc Cestar,Johann Harerend of the 19th century. From that time, histological data have sub- stantially studies of the pioneers in botanical science. From the beginning of the 20th century, the microscope allowed research in cell structure, the general functional unit of living beings. Advances in cytology gradually influe作者: LIKEN 時(shí)間: 2025-3-24 16:32
Johann Harerrhalten von 2016 Basaliomen und 361 spinozellul?ren Karzinomen untersucht. Danach fanden sich in 28% aller Basaliome nach einer mit dem üblichen Sicherheitsabstand von durchschnittlich 3,8 mm durchgeführten Erstexzision noch Tumoranteile am vertikalen Schnittrand, also zur Seite hin. Diese Tumorante作者: cliche 時(shí)間: 2025-3-24 22:01 作者: parsimony 時(shí)間: 2025-3-25 01:28
The Notified Body: The Conformity Assessment Body for Medical Devices in Europe,on (IVDR 2017/746) that assesses the conformity of medical devices for CE marking before they enter the European market. The European member state in which a Notified Body is to be located is responsible for enforcing the organization, quality management, resources and procedural requirements for th作者: 吞噬 時(shí)間: 2025-3-25 06:48
Quality Management Requirements in Compliance with European Regulations,atory for all manufacturers, regardless of the risk class of the products, to introduce, document, apply, maintain, keep up to date, and continuously improve a quality management system. In addition to the requirements in the regulations, the international standard EN ISO 13485 is the central source作者: 書法 時(shí)間: 2025-3-25 08:56
Risk Management for Medical Devices in Compliance with EN ISO 14971, example, it is important to know from the outset which regulations or legal bases apply to risk management. For the implementation of the risk management process, it is important to know which phases it has to go through and which methods and tools are helpful in the implementation. And, of course,作者: offense 時(shí)間: 2025-3-25 13:48
Medical Device Development,r begins with an introduction of regulatory requirements from a European and US perspective, covering the relevant international requirements during development. This is followed by a conceptional development model with user needs, design input, design output, and verification and validation through作者: 拖債 時(shí)間: 2025-3-25 16:54
Safety Requirements for Medical Devices in Compliance with European Standards,t of medical devices is usually not perceived by the user, but it is just as important as the application aspect. This fact is taken into account by the Medical Device and In Vitro Diagnostic Regulations MDR 2017/745 and IVDR 2017/746, and European standards, which require the development of medical作者: squander 時(shí)間: 2025-3-25 22:44 作者: 惡名聲 時(shí)間: 2025-3-26 00:44
Clinical Evaluation and Clinical Investigations of Medical Devices Under the MDR,ical devices (MDs) in the field. This concerned a lack of clear-cut processes, including planning and reporting, and even a lack of sufficient clinical data based on clinical investigation of high-risk MDs, and also the long-term clinical assessment of high-risk devices, like implants needed specifi作者: 枕墊 時(shí)間: 2025-3-26 05:51 作者: defibrillator 時(shí)間: 2025-3-26 12:17 作者: 游行 時(shí)間: 2025-3-26 14:23 作者: 歹徒 時(shí)間: 2025-3-26 20:14
GMP-Compliant Design for Plants Manufacturing Medical Devices,edical device, it starts with a short definition and explains the legal differences..As the field of medical devices is much more diverse than the definition of a medicinal product, there are only very general recommendations mentioned in the various legal documents. This chapter focuses on a specif作者: 饒舌的人 時(shí)間: 2025-3-26 21:41
Integrated Qualification of Manufacturing Systems for Medical Devices,ufacturing Practice (GxP/GMP) in order to allow products to be brought to market. Following GMP rules, the manufacturing system therefore must be “qualified.” The aim of qualification is to provide documented evidence that the manufacturing system and supply systems are built according to approved d作者: miracle 時(shí)間: 2025-3-27 02:39 作者: FICE 時(shí)間: 2025-3-27 07:26 作者: HARP 時(shí)間: 2025-3-27 10:37
Process Validation for Medical Device Manufacturing,ts to artificial organs, and from blood glucose monitoring strips to automated laboratories or computer tomography scanners. Manufacturing these products requires a wide range of process steps that cannot be 100% tested. Deficiencies in processes often only become evident in a later process step or 作者: institute 時(shí)間: 2025-3-27 16:44 作者: semiskilled 時(shí)間: 2025-3-27 19:58
Mastering Quality System Audits and Inspections for Medical Devices,their intended purpose and they shall not compromise the clinical condition or the safety of patients, the safety and health of users, or where applicable, other persons (MDR 2017/745). In order to achieve this, manufacturers of medical and in vitro diagnostic medical devices must have, in accordanc作者: airborne 時(shí)間: 2025-3-28 01:09 作者: 入伍儀式 時(shí)間: 2025-3-28 04:05 作者: 多產(chǎn)子 時(shí)間: 2025-3-28 07:08 作者: expound 時(shí)間: 2025-3-28 11:22 作者: 深淵 時(shí)間: 2025-3-28 15:54 作者: CORE 時(shí)間: 2025-3-28 21:41 作者: neutralize 時(shí)間: 2025-3-29 00:10 作者: Firefly 時(shí)間: 2025-3-29 04:34
Medical Devices and In Vitro Diagnostics978-3-031-22091-3Series ISSN 2731-0493 Series E-ISSN 2731-0507 作者: 漂浮 時(shí)間: 2025-3-29 07:53
https://doi.org/10.1007/978-3-031-22091-3Quality management system for medical devices; Safety Requirements for MDR and IVD-R; GEP/GMP Complian作者: 大包裹 時(shí)間: 2025-3-29 12:20
enale Osteopathie wird noch viel sp?ter apparent, oft erst nach Jahren und ist deshalb Ausdruck einer chronischen Niereninsuffizienz. Vital bedrohliche St?rungen k?nnen sowohl bei akuter als auch bei chronischer Niereninsuffizienz auftreten. Für die Klinik ist die Unterscheidung zwischen akuter und 作者: 整潔 時(shí)間: 2025-3-29 18:51 作者: insolence 時(shí)間: 2025-3-29 22:20 作者: Rheumatologist 時(shí)間: 2025-3-30 03:45 作者: modest 時(shí)間: 2025-3-30 04:04
Robert Neubauer,J?rg Schr?ttner,Christian Baumgartnerure systems has also implicated a number of soluble glycoprotein growth factors. These factors, known as colony-stimulating factors (CSFs), have been shown in vitro to stimulate the proliferation, differentiation and functional activation of cells within different haemopoietic lineages (Metcalf 1984作者: EVADE 時(shí)間: 2025-3-30 10:57
Sara Stoppacher,Peter S. Müllnertor-.; TGF-.) which have the capacity to induce certain transformed phenotypes (see Derynck, this Vol.) and that molecules related to the EGF receptor can function as oncogenes (v.) suggest that parts of the EGF mechanism may have a role in oncogenesis. The importance of understanding this role is u作者: Affection 時(shí)間: 2025-3-30 15:43
Wolfgang Eckerming sarcoma viruses from chickens infected with RSV mutants which contained deletions in the . gene, indicating that c-. sequences can replace v-. sequences in RSV to restore transforming activity (Hanafusa et al. 1977). However, since this rescue occurred via homologous recombination between the r作者: DEBT 時(shí)間: 2025-3-30 20:20
Wolfgang Eckerran, um Details dieser Parameter zu erkl?ren. Die geometrischen ?nderungen der Strahlrichtung und der Wellenfronten sind bei ebenen Fl?chen relativ einfach, so da? im folgenden die Einflüsse auf Amplitude und Phase der optischen Felder im Mittelpunkt stehen.作者: Lasting 時(shí)間: 2025-3-30 23:58 作者: Adjourn 時(shí)間: 2025-3-31 03:44 作者: 生來 時(shí)間: 2025-3-31 08:06 作者: Meditate 時(shí)間: 2025-3-31 11:49 作者: 柏樹 時(shí)間: 2025-3-31 15:46
Brigitte GübitzR nerve terminals and cell bodies within the nucleus tractus solitarii (nTS) and in the nucleus ambiguus [3, 4]. The dynorphin synapses may . operate via kappa-opiate-receptors, and an injection of preferential kappa-opiate agonists into the nucleus ambiguus and nTS produces cardiovascular actions [作者: Maximize 時(shí)間: 2025-3-31 17:57
Johann Harerhe orientation of research, linking in- vestigation to the physiological aspects of cell and tissue differentiation. Among these, the demonstration of the general principles of develop- ment, and the characterization of molecules common to plants and animals, which control and govern the main basic 作者: ethereal 時(shí)間: 2025-3-31 23:12
Johann Harer shifted the orientation of research, linking in- vestigation to the physiological aspects of cell and tissue differentiation. Among these, the demonstration of the general principles of develop- ment, and the characterization of molecules common to plants and animals, which control and govern the main basic 978-3-642-73637-7978-3-642-73635-3作者: 兇兆 時(shí)間: 2025-4-1 05:38 作者: Longitude 時(shí)間: 2025-4-1 07:39 作者: 爭吵加 時(shí)間: 2025-4-1 13:43 作者: 歌劇等 時(shí)間: 2025-4-1 14:43 作者: Congestion 時(shí)間: 2025-4-1 19:30
The Notified Body: The Conformity Assessment Body for Medical Devices in Europe,ter, we present in detail what a Notified Body is in the sense of the aforementioned regulations and what special requirements are placed on designated notified bodies. We describe when a Notified Body is required for CE marking and what the main tasks of a Notified Body are in the conformity assess作者: nepotism 時(shí)間: 2025-4-2 00:33 作者: 熄滅 時(shí)間: 2025-4-2 05:12
Risk Management for Medical Devices in Compliance with EN ISO 14971,its implementation is outlined. In addition, the individual elements of the risk management process are described and discussed in detail. All documents that are considered as evidence of the establishment of a complete risk management process are presented, and their necessary content is shown. The作者: TOXIN 時(shí)間: 2025-4-2 10:08
Safety Requirements for Medical Devices in Compliance with European Standards,es to comply with the state of the art and how it can be achieved. It also provides a brief overview of the safety requirements of the medical device regulations, with a focus on single fault conditions and the philosophy of integrated safety, together with an attempt to identify possible ways of pr作者: 冥界三河 時(shí)間: 2025-4-2 11:26
Software as Medical Device in Europe,t topics are addressed, such as the European Data Protection Regulation or digital health applications on prescription and how, perhaps, the European approach could benefit from FDA approaches. This chapter provides a comprehensive overview on relevant requirements for software as a medical device a
